Suicidal Ideation Framework: Grounded Theory Study, Catalonia
Spain45 participantsStarted 2026-03
Plain-language summary
This doctoral project aims to develop a comprehensive theoretical model of the process through which the suicidal ideation framework is configured as a symbolic, narrative, and relational expression, adopting a multiperspective approach that spans the suicide attempt and the stages of care and recovery. Moving away from biomedical reductionisms, this investigation seeks to identify shared meaning-making nuclei and discursive fractures that reflect the inherent conflictuality of the suicidal act.
Grounded in the integration of the theoretical frameworks previously outlined, this study adopts an interpretive-constructivist approach. Phase 1 will include studies conducted in OECD countries, providing a broad and conceptually diverse interpretive foundation. Phase 2, conducted in Catalonia, will deepen situated configurations, assuming that local sociocultural frameworks act as interpretive prisms for globally relevant phenomena.
Overall, this theoretical-methodological architecture not only ensures conceptual robustness and coherence, but also articulates an ethical and epistemic commitment to understanding suicide through the complexity of its human textures. By centering suffering, listening to historically silenced voices, honoring the singularity of each life trajectory, and grounding the inquiry in an ethics of care, this study aims to transcend a merely technical-instrumental logic of knowledge.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults ≥18 years of age.
* Usual residence in Catalonia (Spain).
* Ability to understand, speak, read, and write in Catalan or Spanish.
* Belonging to one of the three defined analytical groups:
(A) Individuals who have attempted suicide within the past 6 months to 3 years. (B) Members of their family, social, or community support networks. (C) Healthcare professionals directly involved in the care of individuals who have attempted suicide.
* Demonstrated clinical/emotional stability ensuring safe participation, as confirmed by the referring clinician.
* For individuals with lived experience (Group A): at least 6 months since the last suicide attempt or acute clinical crisis.
* For support networks (Group B): having maintained meaningful proximity or involvement during or after the suicide attempt.
* For healthcare professionals (Group C): minimum of 1 year of professional experience in mental health care.
Exclusion Criteria:
* Presence of acute clinical decompensation preventing safe participation.
* Active suicidal risk or acute crisis at the time of recruitment.
* Acute vulnerability identified during screening.
* Inability to provide informed consent.
* Direct hierarchical dependence or conflict of interest with the research team (for Group C).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Conceptual Synthesis of Qualitative Findings.
Timeframe: Through Phase 1 completion, an average of 12-18 months.
2
Emergent Theoretical Model.
Timeframe: Through study completion, an average of 24-30 months.
Trial details
NCT IDNCT07284238
SponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Sponsor typeOTHER
Study typeOBSERVATIONAL
Primary completion2027-04
Contact for this trial
Sergio de la Hera Herrero RN, MSc, DS, Bachelor of Science in Nursing